Trial Outcomes & Findings for Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice (NCT NCT01850589)

Patients will be counseled by the vascular attending/fellow during their office appointment to stop smoking. Counseling will consist of a self-help materials including "Smart Move: A Stop Smoking Guide" from the American Cancer Society and a brief educational discussion on the benefits of smoking cessation. Patients randomized to Group 1 will be offered adjunctive treatment with nicotine replacement therapy at no cost.

8 week comprehensive smoking cessation and pharmacotherapy program consisting of: * 8 one hour group counseling sessions focusing on patient education and behavior modification. * Behavior modifications include cue recognition; coping skills; stress management; and relapse prevention skills. * Counseling includes information on nutrition, exercise, and chemical dependency. All counseling sessions will be held at 256C Mason Avenue. Pharmacotherapy adjuncts offered at no cost are as follows: * Chantix (varenicline) GlaxoSmithKline, * Zyban (bupropion) Pfizer * Nicoderm/Nicorette (nicotine nasal spray, inhaler, transdermal patches and gum) GlaxoSmithKline.

Patients will be counseled by the vascular attending/fellow during their office appointment to stop smoking. Counseling will consist of a self-help materials including "Smart Move: A Stop Smoking Guide" from the American Cancer Society and a brief educational discussion on the benefits of smoking cessation. Patients randomized to Group 1 will be offered adjunctive treatment with nicotine replacement therapy at no cost.

8 week comprehensive smoking cessation and pharmacotherapy program consisting of: * 8 one hour group counseling sessions focusing on patient education and behavior modification. * Behavior modifications include cue recognition; coping skills; stress management; and relapse prevention skills. * Counseling includes information on nutrition, exercise, and chemical dependency. All counseling sessions will be held at 256C Mason Avenue. Pharmacotherapy adjuncts offered at no cost are as follows: * Chantix (varenicline) GlaxoSmithKline, * Zyban (bupropion) Pfizer * Nicoderm/Nicorette (nicotine nasal spray, inhaler, transdermal patches and gum) GlaxoSmithKline.

n=14 Participants

Patients counseled by the vascular attending/fellow during office appointment to stop smoking. Counseling consists of self-help materials including "Smart Move: A Stop Smoking Guide" from the American Cancer Society and a brief educational discussion on the benefits of smoking cessation. Patients randomized to Group 1 will be offered adjunctive treatment with nicotine replacement therapy at no cost.

n=22 Participants

8 week comprehensive smoking cessation and pharmacotherapy program consisting of: * One hour group counseling sessions, focusing on patient education and behavior modification. * Behavior modifications including recognition; coping skills; stress management; and relapse prevention skills. * Counseling including information on nutrition, exercise, and chemical dependency. Counseling sessions will be held 256C Mason Avenue. Pharmacotherapy adjuncts offered at no cost are as follows: Chantix (varenicline) GlaxoSmithKline, Zyban (bupropion) Pfizer,and Nicoderm/Nicorette (nicotine nasal spray, inhaler, transdermal patches and gum) GlaxoSmithKline. Varenicline, Bupropion,and nicotine nasal spray, inhaler, transdermal patches and gum: Pharmacotherapy adjuncts offered at no cost are as follows: * Chantix (varenicline) GlaxoSmithKline, * Zyban (bupropion) Pfizer,and Nicoderm/Nicorette (nicotine nasal spray, inhaler, transdermal patches and gum) GlaxoSmithKline.

n=36 Participants

Total of all reporting groups

n=14 Participants

Patients counseled by the vascular attending/fellow during office appointment to stop smoking. Counseling consists of self-help materials including "Smart Move: A Stop Smoking Guide" from the American Cancer Society and a brief educational discussion on the benefits of smoking cessation. Patients randomized to Group 1 will be offered adjunctive treatment with nicotine replacement therapy at no cost.

n=22 Participants

8 week comprehensive smoking cessation and pharmacotherapy program consisting of: * One hour group counseling sessions, focusing on patient education and behavior modification. * Behavior modifications including recognition; coping skills; stress management; and relapse prevention skills. * Counseling including information on nutrition, exercise, and chemical dependency. Counseling sessions will be held 256C Mason Avenue. Pharmacotherapy adjuncts offered at no cost are as follows: Chantix (varenicline) GlaxoSmithKline, Zyban (bupropion) Pfizer,and Nicoderm/Nicorette (nicotine nasal spray, inhaler, transdermal patches and gum) GlaxoSmithKline. Varenicline, Bupropion,and nicotine nasal spray, inhaler, transdermal patches and gum: Pharmacotherapy adjuncts offered at no cost are as follows: * Chantix (varenicline) GlaxoSmithKline, * Zyban (bupropion) Pfizer,and Nicoderm/Nicorette (nicotine nasal spray, inhaler, transdermal patches and gum) GlaxoSmithKline.